A pilot study evaluating thalidomide therapy in relapsing multiple myeloma

被引：0
|
作者：
Krivanova, A
Hajek, R
Krejci, M
Adam, Z
Scudla, V
Indrak, K
Bacovsky, J
Büchler, T
Svobodnik, A
Pour, L
Vostrejsova, S
Havlikova, K
Mayer, J
Vorlicek, J
机构：
[1] Univ Hosp Brno, Brno, Czech Republic
[2] Univ Hosp Olomouc, Olomouc, Czech Republic
[3] Masaryk Univ, Brno, Czech Republic
来源：
BONE MARROW TRANSPLANTATION | 2005年 / 35卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S49 / S49
页数：1
相关论文
共 50 条
  • [31] Non-thromboembolic pulmonary hypertension in multiple myeloma, after thalidomide treatment: A pilot study
    Lafaras, C.
    Mandala, E.
    Verrou, E.
    Platogiannis, D.
    Barbetakis, N.
    Bischiniotis, T.
    Zervas, K.
    ANNALS OF ONCOLOGY, 2008, 19 (10) : 1765 - 1769
  • [32] Thalidomide maintenance therapy improves survival in patients with multiple myeloma
    Nature Clinical Practice Oncology, 2007, 4 (2): : 67 - 67
  • [33] Bortezomib, Thalidomide, and Dexamethasone as Induction Therapy for Patients With Symptomatic Multiple Myeloma A Retrospective Study
    Kaufman, Jonathan L.
    Nooka, Ajay
    Vrana, Mark
    Gleason, Charise
    Heffner, L. Thompson
    Lonial, Sagar
    CANCER, 2010, 116 (13) : 3143 - 3151
  • [34] Pulmonary hypertension related to thalidomide therapy in refractory multiple myeloma
    Antonioli, E
    Nozzoli, C
    Gianfaldoni, G
    Mannelli, F
    Rossi, S
    Betti, S
    Bernardeschi, P
    Fiorentini, G
    Bosi, A
    ANNALS OF ONCOLOGY, 2005, 16 (11) : 1849 - 1850
  • [35] Effect of thalidomide therapy on bone marrow angiogenesis in multiple myeloma
    Kumar, S
    Witzig, TE
    Dispenzieri, A
    Lacy, MQ
    Wellik, LE
    Fonseca, R
    Lust, JA
    Gertz, MA
    Kyle, RA
    Greipp, PR
    Rajkumar, SV
    LEUKEMIA, 2004, 18 (03) : 624 - 627
  • [36] Deep venous thrombosis and thalidomide therapy for multiple myeloma.
    Osman, K
    Comenzo, R
    Rajkumar, SV
    NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (25): : 1951 - 1952
  • [37] Effect of thalidomide therapy on bone marrow angiogenesis in multiple myeloma
    S Kumar
    T E Witzig
    A Dispenzieri
    M Q Lacy
    L E Wellik
    R Fonseca
    J A Lust
    M A Gertz
    R A Kyle
    P R Greipp
    S V Rajkumar
    Leukemia, 2004, 18 : 624 - 627
  • [38] Does maintenance therapy with thalidomide benefit patients with multiple myeloma?
    Nikhil C Munshi
    Constantine S Mitsiades
    Paul G Richardson
    Kenneth C Anderson
    Nature Clinical Practice Oncology, 2007, 4 : 394 - 395
  • [39] Thalidomide-dexamethasone as primary therapy for advanced multiple myeloma
    Wang, M
    Weber, DM
    Delasalle, K
    Alexanian, R
    AMERICAN JOURNAL OF HEMATOLOGY, 2005, 79 (03) : 194 - 197
  • [40] Tumor lysis syndrome at the beginning of thalidomide therapy for multiple myeloma
    Cany, L
    Fitoussi, O
    Boiron, JM
    Marit, G
    JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (08) : 2212 - 2212
12345